Cited 13 time in
Zolpidem-induced arousal by paradoxical gabaergic stimulation: A case report with F-18 flumazenil positron emission tomography and single photon emission computed tomography study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, C. | - |
| dc.contributor.author | Kwon, B.S. | - |
| dc.contributor.author | Nam, K.Y. | - |
| dc.contributor.author | Park, J.W. | - |
| dc.contributor.author | Lee, H. | - |
| dc.date.accessioned | 2024-09-26T11:00:58Z | - |
| dc.date.available | 2024-09-26T11:00:58Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.issn | 2234-0645 | - |
| dc.identifier.issn | 2234-0653 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/24671 | - |
| dc.description.abstract | Zolpidem is a non-benzodiazepine drug that has selectivity for the gamma-aminobutyric acid (GABA) receptors. We experienced paradoxical effect of zolpidem in a 48-year-old male patient with hypoxic-ischemic brain injury after cardiac arrest. The patient was in stupor and could not communicate. His Glasgow Coma Scale (GCS) was E2M4V2 and Rancho Los Amigos (RLA) was grade III to IV. Zolpidem was prescribed to induce sedation but paradoxically, he became alert (GCS 15, RLA VII) and was able to communicate. The arousal lasted for 2 hours repeatedly following each administration of the medication. While he was alert, electroencephalogram showed the reversal of slow wave into beta range fast activity and F-18 flumazenil positron emission tomography (PET) showed increased GABAergic receptor activity in both frontoparietotemporal cortices. Single photon emission computed tomography (SPECT) also showed increased cerebral perfusion and reversal of cerebellar diaschisis. ©2016 by Korean Academy of Rehabilitation Medicine. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Academy of Rehabilitation Medicine | - |
| dc.title | Zolpidem-induced arousal by paradoxical gabaergic stimulation: A case report with F-18 flumazenil positron emission tomography and single photon emission computed tomography study | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5535/arm.2016.40.1.177 | - |
| dc.identifier.scopusid | 2-s2.0-84959314224 | - |
| dc.identifier.bibliographicCitation | Annals of Rehabilitation Medicine, v.40, no.1, pp 177 - 181 | - |
| dc.citation.title | Annals of Rehabilitation Medicine | - |
| dc.citation.volume | 40 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 177 | - |
| dc.citation.endPage | 181 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002080383 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Arousal | - |
| dc.subject.keywordAuthor | Hypoxia | - |
| dc.subject.keywordAuthor | Zolpidem | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
